Quince Therapeutics, Inc. (QNCX): SCHEDULE 13G/A filed Oct 30, 2025

Form type

SCHEDULE 13G/A

Filing date

Oct 30, 2025

Accession number

0001140361-25-039832

Filer

Quince Therapeutics, Inc. (CIK 1662774)